Gregg H. Alton
2009
In 2009, Gregg H. Alton earned a total compensation of $3.9M as Executive Vice President, Corporate and Medical Affairs at Gilead Sciences, a 27% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $467,351 |
---|---|
Option Awards | $1,615,250 |
Salary | $557,505 |
Stock Awards | $1,237,871 |
Other | $5,400 |
Total | $3,883,377 |
Alton received $1.6M in option awards, accounting for 42% of the total pay in 2009.
Alton also received $467.4K in non-equity incentive plan, $557.5K in salary, $1.2M in stock awards and $5.4K in other compensation.
Rankings
In 2009, Gregg H. Alton's compensation ranked 1,069th out of 9,885 executives tracked by ExecPay. In other words, Alton earned more than 89.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,069 out of 9,885 | 89th |
Division Manufacturing | 373 out of 3,690 | 90th |
Major group Chemicals And Allied Products | 81 out of 866 | 91st |
Industry group Drugs | 54 out of 638 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 6 out of 133 | 96th |
Source: SEC filing on March 22, 2011.
Alton's colleagues
We found five more compensation records of executives who worked with Gregg H. Alton at Gilead Sciences in 2009.
2009
John Martin
Gilead Sciences
Chief Executive Officer
2009
John Milligan
Gilead Sciences
Chief Operating Officer
2009
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2009
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2009
Robin Washington
Gilead Sciences